| Fund ID | 805-6397299051 |
| Fund type | Hedge Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 100% |
| Owned by the adviser or related persons | 10% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 1% |
| Fund | Type | Gross assets |
|---|---|---|
| New Millennium Fundamental Hedged Equity, L.P. | Hedge | $47.9M |
| Telemus Life Science Real Estate Fund, LLC | Other Private | $10.6M |
| Telemus Decorrelation Opportunity Fund, LP | Hedge | $3.4M |
New Millennium Fundamental Hedged Equity Qp, L.P. reports $75.6 million in gross assets, among the top 47% of private funds by size.
The stated minimum investment is $250,000.
New Millennium Fundamental Hedged Equity Qp, L.P. is managed by Kovitz Investment Group Partners, LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.